{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:38:44Z","timestamp":1761514724702,"version":"3.40.5"},"reference-count":28,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/21645515.2021.1883388","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T22:29:57Z","timestamp":1614119397000},"page":"2554-2559","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study"],"prefix":"10.1080","volume":"17","author":[{"given":"Ravish S.","family":"Haradanahalli","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences (KIMS), Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-1605","authenticated-orcid":false,"given":"Rupsa","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Community Processes and Comprehensive Primary Health Care division, National Health Systems Resource Centre, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mysore Sudarshan","family":"Kalappa","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences (KIMS), Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwath","family":"Narayana","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences (KIMS), Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana R.","family":"Annadani","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Karwar Institute of Medical Sciences, Karwar, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangaboraiah","family":"Bilagumba","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences (KIMS), Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"e_1_3_2_2_1","volume-title":"Third report. Technical report series no. 1012","author":"WHO Expert Consultation on Rabies prevention","year":"2018","unstructured":"WHO Expert Consultation on Rabies prevention. Third report. Technical report series no. 1012. Geneva: World Health Organization; 2018."},{"key":"e_1_3_2_3_1","first-page":"201","article-title":"Rabies vaccines: WHO position paper","volume":"93","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Rabies vaccines: WHO position paper. Weekly Epidemiological Record, No. 16. 2018;93:201\u201320.","journal-title":"Weekly Epidemiological Record, No. 16."},{"key":"e_1_3_2_4_1","first-page":"9","volume-title":"Human and dog rabies prevention and control. Report of the WHO\/Bill & Melinda Gates Foundation consultation","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Human and dog rabies prevention and control. Report of the WHO\/Bill & Melinda Gates Foundation consultation. Annecy (France); 2009. p. 9."},{"issue":"5","key":"e_1_3_2_5_1","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel DL","year":"2005","unstructured":"Knobel DL, Cleaveland S, Coleman PG, F\u00e8vre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin F-X. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005;83(5):360\u201368.","journal-title":"Bull World Health Organ"},{"volume-title":"World Health Organization. Rabies vaccines and immunoglobulins: WHO position,WHO\/CDS\/NTD\/NZD\/2018.04. Geneva (Switzerland): World Health Organization","year":"2018","key":"e_1_3_2_6_1","unstructured":"World Health Organization. Rabies vaccines and immunoglobulins: WHO position,WHO\/CDS\/NTD\/NZD\/2018.04. Geneva (Switzerland): World Health Organization; 2018."},{"key":"e_1_3_2_7_1","volume-title":"Second report. Technical report series no. 931","author":"World Health Organization. WHO Expert Consultation on Rabies","year":"2005","unstructured":"World Health Organization. WHO Expert Consultation on Rabies. Second report. Technical report series no. 931. Geneva (Switzerland): World Health Organization; 2005."},{"key":"e_1_3_2_8_1","first-page":"10","volume-title":"8th report. Technical report series no.824","author":"World Health Organization. WHO Expert Committee on Rabies","year":"1992","unstructured":"World Health Organization. WHO Expert Committee on Rabies. 8th report. Technical report series no.824. Geneva (Switzerland): World Health Organization; 1992. p. 10\u201316."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-557X.152867"},{"key":"e_1_3_2_10_1","volume-title":"Second report. Technical report series no. 982","author":"World Health Organization. WHO Expert Consultation on Rabies","year":"2013","unstructured":"World Health Organization. WHO Expert Consultation on Rabies. Second report. Technical report series no. 982. Geneva (Switzerland): World Health Organization; 2013."},{"issue":"02","key":"e_1_3_2_11_1","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for post-exposure prophylaxis to prevent human rabies","volume":"59","author":"The Morbidity and Mortality Weekly Report, Center for Disease Control and Prevention (CDC)","year":"2010","unstructured":"The Morbidity and Mortality Weekly Report, Center for Disease Control and Prevention (CDC). Use of a reduced (4-dose) vaccine schedule for post-exposure prophylaxis to prevent human rabies. Recommend Advisory Committee Immun Prac. 2010;59(RR02):1\u201310.","journal-title":"Recommend Advisory Committee Immun Prac"},{"issue":"1","key":"e_1_3_2_12_1","first-page":"32","article-title":"An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey","volume":"38","author":"Sudarshan MK","year":"2006","unstructured":"Sudarshan MK, Mahendra BJ, Madhusudana SN, Ashwoath Narayana DH, Rahman A, Rao NS, Meslin X, Lobo F, Ravikumar D, Gangaboraiah K. An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. J Commun Dis. 2006;38(1):32\u201339. PMID:17370688","journal-title":"J Commun Dis"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(79)80024-4"},{"key":"e_1_3_2_14_1","unstructured":"World Health Organization. Rabies post exposure prophylaxis. [accessed 2017 Jul 20]. http:\/\/www.who.int\/rabies\/human\/postexp."},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003709"},{"key":"e_1_3_2_16_1","unstructured":"World Health Organization. Rabies. [accessed 2017 Jul 18]. http:\/\/www.who.int\/mediacentre\/factsheets."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.030"},{"key":"e_1_3_2_18_1","unstructured":"WHO South East Asia region: strategic framework for elimination of human rabies transmitted by dogs in the South-East Asia Region: world Health Organization Regional office for South East Asia; 2012."},{"key":"e_1_3_2_19_1","first-page":"32","volume-title":"Rabies","author":"Jackson AC","year":"2007","unstructured":"Jackson AC, William HW. Rabies. 2nd ed. London (United Kingdom): Elsevier academic press; 2007. p. 32\u201356.","edition":"2"},{"key":"e_1_3_2_20_1","first-page":"7","article-title":"Purified chick embryo cell rabies vaccine for human use","volume":"1","author":"Barth R","year":"1984","unstructured":"Barth R, Bijok U, Gruschkau H, Smerdel S, Vodopija I. Purified chick embryo cell rabies vaccine for human use. Lancet. 1984;1:7.","journal-title":"Lancet"},{"issue":"77","key":"e_1_3_2_21_1","first-page":"109","article-title":"Rabies vaccines, WHO position paper","volume":"14","author":"World Health Organization (WHO)","year":"2002","unstructured":"World Health Organization (WHO). Rabies vaccines, WHO position paper. Weekly Epidemiological Record. 2002 Apr 5;14(77):109\u201320.","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00312-X"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(86)90138-6"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90244-Z"},{"issue":"1","key":"e_1_3_2_25_1","first-page":"1","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"28","author":"Rupprecht CE","year":"2009","unstructured":"Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine. 2009;28(1):1\u20138.","journal-title":"Vaccine"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.4.5588"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.10.002"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.090"},{"key":"e_1_3_2_29_1","unstructured":"Sustainable development goals: 17 goals to transform our world. Goal 3: ensure healthy lives and promote well-being for all at all ages. [accessed 2018 Feb 16]. http:\/\/www.un.org\/sustainabledevelopment\/health."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1883388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:56:56Z","timestamp":1709305016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1883388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/21645515.2021.1883388"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1883388","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2021,2,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}